title: Modulation of endogenous antioxidant defense and the progression of kidney disease in multi-heritage groups of patients with type 2 diabetes: PRospective EValuation of Early Nephropathy and its Treatment (PREVENT).
abstract: Diabetes is the western world's leading cause of end-stage renal disease. Glucose-dependent, oxidative stress is linked to the development of renal inflammation and sclerosis, which, in animal models of diabetes, can be prevented by anti-oxidative treatment. Patients of non-Caucasian heritage have low activity of the selenoprotein, antioxidant enzyme, glutathione peroxidase (GPx) and its co-factor vitamin E, which may be linked to their increased propensity to developing end-stage renal disease.
  
  
  
  We have designed a double-blind, randomized, placebo controlled study with selenium and/or vitamin E versus placebo as the interventions for patients with type 2 diabetes and chronic kidney disease (CKD) stages 1-3. A 2 × 2 factorial design will allow a balanced representation of the heritage groups exposed to each intervention. The primary biochemical outcome is change in GPx activity, and clinical outcome measure is the actual, rate of-and/or percentage change in estimated glomerular filtration rate (eGFR) from baseline. Analysis will be with a marginal model for longitudinal data using Generalized Estimating Equations corrected for measures of baseline serum antioxidant enzyme activities (GPx, superoxide dismutase and catalase), micronutrient levels (vitamins E and C), measures of inflammation (interleukin 6, c-reactive protein and monocyte chemoattractant protein-1) and markers of oxidative damage (plasma 8-isoprostaglandin F2α and urinary 8-hydroxydeoxyguanosine).
  
  
  
  The study will assess the relationship between GPx activity, oxidative stress, inflammation and eGFR. It will test the null hypothesis that antioxidant therapy does not influence the activity of GPx or other antioxidant enzymes and/or alter the rate of change in eGFR in these patient groups.
  
  
  
  Outcome data on the effect of antioxidants in human diabetic renal disease is limited. Previous post hoc analyses have not shown a beneficial effect of vitamin E on renal function. A recent trial of a pharmaceutical antioxidant agent, improved eGFR, but in patients with advanced diabetes-related chronic kidney disease its use was associated with an increased incidence of cardiovascular events. We will explore whether the nutritional antioxidants, vitamin E and selenium alone, or in combination in patients at high risk of renal disease progression, forestalls a reduction in eGFR. The study will describe whether endogenous antioxidant enzyme defenses can be safely modified by this intervention and how this is associated with changes in markers of oxidative stress. Trial registration ISRCTN 97358113. Registered 21st September 2009.
authors: St Georges University Hospitals NHS Foundation Trust, Blackshaw Road, London, SW 17 0RE, UK. kearle@sgul.ac.uk.|Clinical Sciences Division, St. Georges University of London, London, UK. kearle@sgul.ac.uk.
authors: Kenneth A
authors: 0000-0002-2903-5763
authors: KA
authors: Earle
authors: Clinical Sciences Division, St. Georges University of London, London, UK.
authors: Karima
authors: K
authors: Zitouni
authors: Richmond University, Staten Island, New York, USA.
authors: John
authors: J
authors: Pepe
authors: St Georges University Hospitals NHS Foundation Trust, Blackshaw Road, London, SW 17 0RE, UK.|Clinical Sciences Division, St. Georges University of London, London, UK.
authors: Maria
authors: M
authors: Karaflou
authors: Department of Preventive Medicine, Icahn School of Medicine at Mount Sinai, New York, USA.
authors: James
authors: J
authors: Godbold
mesh_terms: D000328:Adult; D000975:Antioxidants / Q000378:metabolism*; D003924:Diabetes Mellitus, Type 2 / Q000378:metabolism* / Q000473:pathology*; D003928:Diabetic Nephropathies / Q000517:prevention & control* / Q000628:therapy*; D018450:Disease Progression; D005006:Ethnicity; D006801:Humans; D011446:Prospective Studies
chemical_list: D000975:Antioxidants